Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19: A multicenter retrospective study.
Dequidt T, Richier Q, Louapre C, Ader F, Merad Y, Lauwerier N, Jacomet C, Carles M, Biron C, Gendrin V, Marlat C, Danion F, Lepage TM, Sotto A, Bourdellon L, Mania A, Martinot M, Falher GL, Ferre A, Pilmis B, Gondran G, Simeone P, Henry M, Kamel T, Ray S, Ancellin S, Mélé N, Camou F, Destremau M, Sellenet J, Zucman N, Le Maréchal M, Mellouki K, Langlois ME, Luque Paz D, Mousset M, Leclerc C, Sommet A, Lacombe K, Martin-Blondel G.
Dequidt T, et al. Among authors: merad y.
Int J Infect Dis. 2025 Feb;151:107323. doi: 10.1016/j.ijid.2024.107323. Epub 2024 Dec 4.
Int J Infect Dis. 2025.
PMID: 39643155
Free article.